These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34633845)

  • 1.
    Bidaud AL; Schwarz P; Chowdhary A; Dannaoui E
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0144921. PubMed ID: 34633845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America.
    Cañete-Gibas CF; Mele J; Patterson HP; Sanders CJ; Ferrer D; Garcia V; Fan H; David M; Wiederhold NP
    J Clin Microbiol; 2023 Aug; 61(8):e0056223. PubMed ID: 37432126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Gradient Concentration Strips for Detection of Terbinafine Resistance in
    Bidaud AL; Moreno-Sabater A; Normand AC; Cremer G; Foulet F; Brun S; Ayachi A; Imbert S; Chowdhary A; Dannaoui E
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0171622. PubMed ID: 37162356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of terbinafine-resistant Trichophyton indotineae isolates within the Trichophyton mentagrophytes species complex isolated from patients in Hue City, Vietnam: A comprehensive analysis.
    Ngo TMC; Santona A; Ton Nu PA; Cao LC; Tran Thi G; Do TBT; Ha TNT; Vo Minh T; Nguyen PV; Ton That DD; Nguyen Thi Tra M; Bui Van D
    Med Mycol; 2024 Aug; 62(8):. PubMed ID: 39174488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.
    Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged treatment of dermatophytosis caused by Trichophyton indotinea with terbinafine or itraconazole impacts better outcomes irrespective of mutation in the squalene epoxidase gene.
    Shaw D; Dogra S; Singh S; Shah S; Narang T; Kaur H; Walia K; Ghosh A; Handa S; Chakrabarti A; Rudramurthy SM
    Mycoses; 2024 Aug; 67(8):e13778. PubMed ID: 39086026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro Azole Susceptibility Testing of Japanese Isolates of Itraconazole-Resistant Dermatophytes.
    Nojo H; Hiruma J; Noguchi H; Hiruma M; Harada K; Makimura K; Kano R
    Med Mycol J; 2023; 64(4):103-105. PubMed ID: 38030274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
    Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
    Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial effect of fluconazole, itraconazole, and terbinafine with different culture extracts of Candida parapsilosis and Trichophyton spp. against Trichophyton rubrum.
    Lemes TH; Nascentes JAS; Regasini LO; Siqueira JPZ; Maschio-Lima T; Pattini VC; Ribeiro MD; de Almeida BG; de Almeida MTG
    Int Microbiol; 2024 Jun; 27(3):899-905. PubMed ID: 37875749
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Singh SK; Patwa DK; Tilak R; Das A; Singh TB
    Indian J Dermatol Venereol Leprol; 2019; 85(4):388-392. PubMed ID: 30950409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton.
    Arendrup MC; Kahlmeter G; Guinea J; Meletiadis J;
    Clin Microbiol Infect; 2021 Jan; 27(1):55-60. PubMed ID: 32916260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an agar-based screening method for terbinafine, itraconazole, and amorolfine susceptibility testing of
    Siopi M; Efstathiou I; Arendrup MC; Meletiadis J
    J Clin Microbiol; 2024 Jan; 62(1):e0130823. PubMed ID: 38117081
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Rezaei-Matehkolaei A; Khodavaisy S; Alshahni MM; Tamura T; Satoh K; Abastabar M; Shokoohi GR; Ahmadi B; Kord M; Taghipour S; Makimura K; Badali H
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
    Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
    Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Gupta AK; Kohli Y; Batra R
    Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of in vitro biofilm formation by clinical isolates of dermatophyte and antibiofilm activity of common antifungal drugs.
    Yazdanpanah S; Sasanipoor F; Khodadadi H; Rezaei-Matehkolaei A; Jowkar F; Zomorodian K; Kharazi M; Mohammadi T; Nouripour-Sisakht S; Nasr R; Motamedi M
    Int J Dermatol; 2023 Jan; 62(1):120-127. PubMed ID: 35780324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for
    Sardana K; Sharath S; Khurana A; Ghosh S
    Expert Rev Anti Infect Ther; 2023; 21(9):977-991. PubMed ID: 37606343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing?
    Shen JJ; Arendrup MC; Verma S; Saunte DML
    Dermatology; 2022; 238(1):60-79. PubMed ID: 34058736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.